G 2/06

From Wikipedia, the free encyclopedia
Jump to: navigation, search
G 2/06
Scale of justice.png

Enlarged Board of Appeal of the European Patent Office

Issued November 25, 2008
Board composition
Chairman: Peter Messerli
Members: S. Perryman, P. Alting van Geusau, U. Kinkeldey, M. Scuffi, J.-P. Seitz, O. Spineanu-Matel
Headwords
Stem cells

G 2/06 is a decision of the Enlarged Board of Appeal of the European Patent Office (EPO), which was issued on November 25, 2008. The Enlarged Board of Appeal decided that, under the European Patent Convention (EPC), a patent cannot be granted for an invention which necessarily involves the use and destruction of human embryos.[1][2] The decision notably refers to the provisions of EU Directive 98/44/EC of 6 July 1998 on the legal protection of biotechnological inventions,[1] referred to in Rule 26(1) EPC.

The reactions to the decision were mixed. According to Reuters, the decision could stifle research by stem cell companies for commercial purposes.[3] In contrast, according to the Guardian, "some experts believe this will provide a boost for European companies developing technologies based on human embryonic stem cells".[4]

See also[edit]

References[edit]

  1. ^ a b No European patent for WARF/Thomson stem cell application, EPO web site, News, November 27, 2008. Consulted on November 28, 2008.
  2. ^ Stephanie Bodoni, Wisconsin stem cell patent refused by European agency, Independent.ie, November 28, 2008. Consulted on November 28, 2008.
  3. ^ UPDATE 1-European agency rules against stem cell patents, Reuters, November 27, 2008. Consulted on November 28, 2008.
  4. ^ James Randerson, Europe rejects patent governing use of embryonic stem cells, guardian.co.uk, November 27, 2008. Consulted on November 28, 2008.

External links[edit]